AHA Scientific Sessions 2025 Abstract
Acoramidis Reduces All-Cause Mortality and Cardiovascular-Related Hospitalizations Through Month 42 in Transthyretin Amyloid Cardiomyopathy Across All Pre-specified Patient Subgroups
Trial in peopleInterventions
Papers by Matthew J. Maurer
2 results
- AHA Scientific Sessions 2025 Abstract
Diagnostic Performance of the ATTR-CM Mayo Score in Black and Hispanic individuals: Findings from SCAN-MP
Study in peopleBiomarkers